Jeegar Patel

582 citations

25 papers · 426 indexed · h-index 9

Impact in

Virology top 10%
- HIV Research and Treatment
Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Transplantation 3
- Renal Transplantation Outcomes and Treatments 3
Immunology 13
- Immune Cell Function and Interaction 8

Co-authors: Muhammad Zafrullah Khan Olimpia Meucci Giuseppe Bardi Rajarshi Sengupta Olivier Schueller Alessandro Fatatis Renato Brandimarti Carlos Bachier
Journals: Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Oncology (2 papers)Journal of NeuroVirology (2 papers)The Journal of Immunology (1 paper)
Partner nations: United States United Kingdom Italy

In The Last Decade

Jeegar Patel

24 papers receiving 418 citations

Peers

Countries citing papers authored by Jeegar Patel

Since Specialization

Citations

This map shows the geographic impact of Jeegar Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeegar Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeegar Patel more than expected).

Fields of papers citing papers by Jeegar Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeegar Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeegar Patel. The network helps show where Jeegar Patel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jeegar Patel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeegar Patel Line = papers co-authored together Jeegar Patel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In Vitro and Clinical Evaluations of UGT1A1‐, P‐gp‐, OATP1B1‐, and BCRP‐Mediated Drug–Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor The Journal of Clinical Pharmacology ·Olivier Schueller, Lauren Lohmer, Débora L. Shambo-Rodríguez, Jeegar Patel, Jasminder Sahi	2025	0
2	Transcriptional profiling of primary human-skin derived mast cell activation by various MRGPRX2 agonists and inhibition with EVO756 The Journal of Immunology ·Sreya Bagchi, Jeegar Patel, Jamie L. Harden	2024	1
3	Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants Clinical Pharmacology in Drug Development ·Olivier Schueller, Laurie A. Sovell, Nand K. Singh, Shawneda Crout Marks, Akram Alshwabekah, 신동안, Lauren Lohmer, Jeegar Patel	2024	4
4	Abstract 2972: Preclinical characterization of SAR445877, an anti-PD-1 antibody-IL-15 mutein fusion protein with robust anti-tumor efficacy as monotherapy and in combination with PD-L1 blockade Cancer Research ·Rasheeda Mohamedali, Yuan Zhang, Dan Lu, Stella Martomo, Ranil Karunamuni de Silva, Zhu Chen, Raymond P. Perez, Jeegar Patel, Donald R. Shaffer, Xiangming Li	2023	1
5	Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo Cancer Immunology Immunotherapy ·Stella Martomo, Jeegar Patel	2022	3
6	A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors Clinical Pharmacology in Drug Development ·Olivier Schueller, Shawneda Crout Marks, Nand K. Singh, Lauren Lohmer, Tiina Kinnunen, Jeegar Patel	2022	10
7	Abstract 5215: MOA study of KD050, an anti-PD-1/IL-15 bi-functional antibody selectively targeted PD-1 positive tumor-infiltrating lymphocytes resulted in robust anti-tumor activity and low systemic toxicity Cancer Research ·楊秉訓, Gregory Vereshchag, Stella Martomo, Nathan Blyler, Zhikai Zhang, Stanley Ng, Norman T. Simms, Jeegar Patel, Dan Lu	2022	1
8	Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects Clinical Pharmacology in Drug Development ·Olivier Schueller, John McDermott, Daniel Kärcher, Lauren Lohmer, Tiina Kinnunen, Jeegar Patel	2022	6
9	A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects Clinical Pharmacology in Drug Development ·Olivier Schueller, Lauren Lohmer, Taheri Sa, Börje Darpö, Jeegar Patel	2022	2
10	Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors Cell chemical biology ·Kellen Olszewski, Anthony M. Barsotti, Xiao‐Jiang Feng, Milica Momcilovic, 刘益平, Ji‐In Kim, 健二奥野, عمار باسم صالح, Shou-Fu, Xuemei Yu, Jeegar Patel, Joshua D. Rabinowitz, David B. Shackelford, Masha V. Poyurovsky	2021	44
11	Functional antibody characterization via direct structural analysis and information‐driven protein–protein docking Proteins Structure Function and Bioinformatics ·Rafael S. Depetris, Dan Lü, 楊秉訓, Zhikai Zhang, Nathan Blyler, Chengliang MIAO, José Carlos da Silva Oliveira, Michael L. Drummond, Michael Che Ming Chan, Maximilian C. C. J. C. Ebert, Jeegar Patel, Masha V. Poyurovsky	2021	5
12	512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors SHILAP Revista de lepidopterología ·Jason J. Luke, Anthony J. Olszanski, Igor Puzanov, Christos Fountzilas, Lee S. Rosen, Dan Lu, E. Fiorina, Stella Martomo, Olivier Schueller, David Eiznhamer, Norman T. Simms, Chen Min-yo, Jeegar Patel	2021	1
13	Single-Dose Anti–PD-L1/IL-15 Fusion Protein KD033 Generates Synergistic Antitumor Immunity with Robust Tumor-Immune Gene Signatures and Memory Responses Molecular Cancer Therapeutics ·Stella Martomo, Dan Lü, 楊秉訓, Nathan Blyler, Zhikai Zhang, Arun Kumar Singh Gangwar, S.F. Hardman, Day Pj, Daniel N. Silva, Jeegar Patel	2020	22
14	573 A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity SHILAP Revista de lepidopterología ·Dan Lu, 楊秉訓, Gregory Vereshchag, Stella Martomo, Nathan Blyler, Zhikai Zhang, Stanley S. Ng, Daniel N. Silva, Jeegar Patel	2020	1
15	Abstract C173: Anti-PD-L1 antibody-based IL-15 immunocytokine has enhanced antitumor immunity Molecular Cancer Therapeutics ·Yan Wu, Zhaojing Zhong, Stella Martomo, Dan Lu, 楊秉訓, Nathan Blyler, Haifan Zhang, Zhikai Zhang, Zhun Wang, Chengxi Liu, Jeegar Patel, James R. Tonra, Henry Li, Larry Witte, 李永华 Li Yonghua, Zhenping Zhu	2015	1
16	Abstract 2590: KD019: Blood brain barrier penetrant HER2/neu, Src, and EGFR inhibitor Cancer Research ·James R. Tonra, Masha V. Poyurovsky, 刘益平, Jeegar Patel, H. M�nstedt, Robert D. Tilton, John L. Ryan, Mark S. Berger, Larry Witte, Ji‐In Kim, Samuel D. Waksal	2015	7
17	Human immunodeficiency virus gp120-induced apoptosis of human neuroblastoma cells in the absence of CXCR4 internalization Journal of NeuroVirology ·Giuseppe Bardi, Rajarshi Sengupta, Muhammad Zafrullah Khan, Jeegar Patel, Olimpia Meucci	2006	38
18	Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO Journal of NeuroVirology ·Jeegar Patel, Rajarshi Sengupta, Giuseppe Bardi, Muhammad Zafrullah Khan, Peiqian Li, Olimpia Meucci	2006	50
19	Regulation of neuronal P53 activity by CXCR4 Molecular and Cellular Neuroscience ·Muhammad Zafrullah Khan, Saori Shimizu, Jeegar Patel, M.‐C. BERGOGNE, Yiyi Liu, Peiqian Li, Renato Brandimarti, Alessandro Fatatis, Olimpia Meucci	2005	40
20	Apoptotic and Antiapoptotic Effects of CXCR4: Is It a Matter of Intrinsic Efficacy? Implications for HIV Neuropathogenesis AIDS Research and Human Retroviruses ·Muhammad Zafrullah Khan, Renato Brandimarti, Jeegar Patel, Akram Mirzae, Jun Wang, Ziwei Huang, Alessandro Fatatis, Olimpia Meucci	2004	44

About Jeegar Patel

Jeegar Patel is a scholar working on Transplantation, Immunology, Oncology, Hematology and Virology, having authored 25 papers that have together received 426 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (8 papers), Chemokine receptors and signaling (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), Biochemical and Molecular Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Virology (77 citations), Neurology (68 citations), Hematology (73 citations), Immunology (130 citations) and Transplantation (13 citations). Jeegar Patel has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Muhammad Zafrullah Khan, Olimpia Meucci, Giuseppe Bardi, Rajarshi Sengupta, Olivier Schueller, Alessandro Fatatis, Renato Brandimarti, Carlos Bachier, Bruce R. Blazar and Behyar Zoghi. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Journal of NeuroVirology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact